1 |
Stanldy JR, Freedberg IM, Eizen AZ, Wolff K, Austen KF, Goldsmith LA, et al. Fitzpatrick's dermatology in general medicine. 6th ed. New York:McGraw-Hill. 2003:558-67.
|
2 |
Kim BD, Kim SC. Clinical study of Korean patients with pemphigus. Kor J Dermatol. 2005;43(8):1077-84.
|
3 |
Seo HS, Yoon HJ. Text of Traditional Korean Dermatolog&Surgery. J Korean Med Ophthalmol Otolaryngol Dermatol. 2007:400-3.
|
4 |
Lee CW. Autoimmune diseases of the skin. 1st ed. Seoul:Academia. 2002:9-42.
|
5 |
Katz SL. Blistering skin disease. N Engl J Med. 1985;313:1657-8.
DOI
|
6 |
McCuin JB, Hanlon T, Mutasim DF. Autoimmune bullous disease: diagnosis and management. Dermatol Nurs. 2006;18:20-5.
|
7 |
GammonWR, Fine JD, Forbes M, Briggaman RA. Immuno-flourescence on split skin for the detection and differentiation of basement membrane zone autoantibodis. J Am Acad Dermatol. 1992;27:79-87.
DOI
|
8 |
Udey MC, Stanley JR. Pemphigus-disease of antidesmosomal autoimmunity. JAMA. 1999;282:572-6.
DOI
|
9 |
Amagai M. Autoimmunity against desmosomal cadherins in pemphigus. J Dermatol Sei. 1999;20:92-102.
DOI
|
10 |
Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodis against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 1991;67:869-77.
DOI
|
11 |
Stanley JR. Update; structure and function of pemphigus vulgaris antigen. J Dermatol. 1997;24:741-3.
DOI
|
12 |
Lo ML, Pannone G, Staibano S, Mignogna MD, Rubini C, Farronato G, et al. Strict correlation between uPAR and plakoglobin expression in pemphigus vulgaris. J Cutan Pahol. 2002;29:540-8.
DOI
|
13 |
Esaki C, Seishima M, Yamada T, Osada K, Kitajima Y. Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-triphophate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-2 cells, a squamous cell carcinoma line. J Invest Dermatol. 1995;105:329-33.
DOI
|
14 |
Puviani M, Marconi A, Cozzani E, Pincelli C. Fas ligand in pemhigus sera induces keratinocyte apoptosis through the activation of caspase-8. J invest Dermatol. 2003;120:164-7.
DOI
|
15 |
Wang X, Bregegere F, Frusic-Zlotkin M, Feinmesser M, Michel B, Milner Y. Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. Apoptosis. 2004;9:131-43.
DOI
|
16 |
Frusic-Zlotkin M, Pergamentz R, Michel B, David M, Minouni D, Bregegere F, et al. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients. Ann NY Acad Sei. 2005;1050:371-9.
DOI
|
17 |
Roh BH, Whang KU, Cho MK, Park UL, Lee JS, Lee CW. A Study of apoptosis in pemphigus vulgaris. Korean J Dermatol. 2007;45(7):650-8.
|
18 |
Hashimoto K, Shafran KM, Webber PS, Singer KH. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cell; A mechanism for the loss of epidermal cohesion and blister formation. J Exp. 1983;157:259.
DOI
|
19 |
Lee SS, Oh HS, Lee MH, Kim NI, Haw CR. A case of pemphigus vulgaris associated with eye involvement. The journal of Kyung Hee University medical center. 1987;3(4):558-63.
|
20 |
Bystryn JC. Adjuvant therapy of pemphigus. Arch Dermatol. 1984;120:941.
DOI
|
21 |
Huilgol SC, Black MM. Management of the immunobullous disorders Ⅱ, Pemphigus. Clin Exp Dermatol. 1995;20:283-93.
DOI
|
22 |
Lever WF, Schaunburg LG. Treatment of pemphigu vularis. Arch Dermatol. 1984;120:44.
DOI
|
23 |
Park BS, Chung JH. Treatment of pemphigus. Korean J Dermatol. 1997;35:465-74.
|
24 |
Seo PG, Choi WW, Chung JH. Pemphigus in Korea: clinical manifestations and treatment protocol. J Dermatol. 2003;30:782-8.
DOI
|
25 |
Carson PJ, Hameed A, Ahmed AR. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol. 1996;34:645-52.
DOI
|
26 |
Heo J. DongEuiBoGam. Seoul:Dongeuibogamchulpansa. 2010:831,727,464,314.
|